Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery

Zhang,Bin; Zhang,Yueying; Yu,Dongmei

doi:10.3892/or.2016.5298

Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery

Authors:
- Bin Zhang
- Yueying Zhang
- Dongmei Yu
View Affiliations

Affiliations: Department of Oncology, Shandong Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China, Department of Experimental Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan, Shandong 250062, P.R. China, Department of Public Health, Shandong Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China
Published online on: December 7, 2016 https://doi.org/10.3892/or.2016.5298
Pages: 937-944

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

To achieve lung cancer gene therapy, nanocarriers decorated with different ligands were used. Surface decoration and nanoparticulate system will assist in targeting the gene to specific cells and tissues, such as cancers and diseased organs. The aim of this research was to develop a dual ligand-decorated nanocarriers, which could target the tumor cells through receptor-mediated pathways to increase the uptake of genetic materials. Transferrin (Tf) and hyaluronic (HA) containing polyethylene glycol-distearoylphosphatidylethanolamine (Tf-PEG-DSPE and HA-PEG-DSPE) ligands were synthesized. Novel Tf and HA ligand-decorated, plasmid-enhanced green fluorescent protein loaded nanostructured lipid carriers (Tf/HA-pDNA NLC) was constructed. Physicochemical properties such as morphology, size, and ζ-potential as well as release properties were evaluated. The in vitro and in vivo gene transfection efficiency of Tf/HA-pDNA NLC was evaluated in lung adenocarcinoma A549 cells and lung cancer bearing animal models. Tf/HA-pDNA NLC displayed significantly higher transfection efficiency than undecorated DNA-NLCs and single ligand-decorated NLCs in vitro and in vivo. The newly constructed NLCs could successfully load gene; and Tf and HA functioned as excellent targeting ligands to improve the cell targeting ability of the gene-loaded nanocarriers. The resulting dual ligands decorated vectors could be a promising targeted gene delivery system for the lung cancer treatment.

View Figures

View References

1	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
2	Poulsen TT, Pedersen N and Poulsen HS: Replacement and suicide gene therapy for targeted treatment of lung cancer. Clin Lung Cancer. 6:227–236. 2005. View Article : Google Scholar : PubMed/NCBI
3	Stuckey DW and Shah K: Stem cell-based therapies for cancer treatment: Separating hope from hype. Nat Rev Cancer. 14:683–691. 2014. View Article : Google Scholar : PubMed/NCBI
4	Zhang TY, Huang B, Wu HB, Wu JH, Li LM, Li YX, Hu YL, Han M, Shen YQ, Tabata Y, et al: Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice. J Control Release. 209:260–271. 2015. View Article : Google Scholar : PubMed/NCBI
5	Cho WY, Hong SH, Singh B, Islam MA, Lee S, Lee AY, Gankhuyag N, Kim JE, Yu KN, Kim KH, et al: Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA. Eur J Pharm Biopharm. 94:450–462. 2015. View Article : Google Scholar : PubMed/NCBI
6	Kim I, Byeon HJ, Kim TH, Lee ES, Oh KT, Shin BS, Lee KC and Youn YS: Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer. Biomaterials. 34:6444–6453. 2013. View Article : Google Scholar : PubMed/NCBI
7	Merdan T, Kopecek J and Kissel T: Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev. 54:715–758. 2002. View Article : Google Scholar : PubMed/NCBI
8	Xie RL, Jang YJ, Xing L, Zhang BF, Wang FZ, Cui PF, Cho MH and Jiang HL: A novel potential biocompatible hyperbranched polyspermine for efficient lung cancer gene therapy. Int J Pharm. 478:19–30. 2015. View Article : Google Scholar : PubMed/NCBI
9	Christensen CL, Zandi R, Gjetting T, Cramer F and Poulsen HS: Specifically targeted gene therapy for small-cell lung cancer. Expert Rev Anticancer Ther. 9:437–452. 2009. View Article : Google Scholar : PubMed/NCBI
10	Chen Y, Gao DY and Huang L: In vivo delivery of miRNAs for cancer therapy: Challenges and strategies. Adv Drug Deliv Rev. 81:128–141. 2015. View Article : Google Scholar : PubMed/NCBI
11	Chen Y, Zhu X, Zhang X, Liu B and Huang L: Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther. 18:1650–1656. 2010. View Article : Google Scholar : PubMed/NCBI
12	Lennox KA and Behlke MA: Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther. 18:1111–1120. 2011. View Article : Google Scholar : PubMed/NCBI
13	Tivnan A, Orr WS, Gubala V, Nooney R, Williams DE, McDonagh C, Prenter S, Harvey H, Domingo-Fernández R, Bray IM, et al: Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles. PLoS One. 7:e381292012. View Article : Google Scholar : PubMed/NCBI
14	Heger Z, Gumulec J, Cernei N, Tmejova K, Kopel P, Balvan J, Masarik M, Zitka O, Beklova M, Adam V, et al: 17β-estradiol-containing liposomes as a novel delivery system for the antisense therapy of ER-positive breast cancer: An in vitro study on the MCF-7 cell line. Oncol Rep. 33:921–9. 2015.PubMed/NCBI
15	de Jesus MB and Zuhorn IS: Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms. J Control Release. 201:1–13. 2015. View Article : Google Scholar : PubMed/NCBI
16	Zhang Z, Sha X, Shen A, Wang Y, Sun Z, Gu Z and Fang X: Polycation nanostructured lipid carrier, a novel nonviral vector constructed with triolein for efficient gene delivery. Biochem Biophys Res Commun. 370:478–482. 2008. View Article : Google Scholar : PubMed/NCBI
17	Doktorovova S, Souto EB and Silva AM: Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data. Eur J Pharm Biopharm. 87:1–18. 2014. View Article : Google Scholar : PubMed/NCBI
18	Han Y, Zhang Y, Li D, Chen Y, Sun J and Kong F: Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomed. 9:4107–4116. 2014.
19	Avitabile T, Marano F, Castiglione F, Bucolo C, Cro M, Ambrosio L, Ferrauto C and Reibaldi A: Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits. Biomaterials. 22:195–200. 2001. View Article : Google Scholar : PubMed/NCBI
20	Fang XJ, Jiang H, Zhu YQ, Zhang LY, Fan QH and Tian Y: Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells. Oncol Rep. 31:2735–2742. 2014.PubMed/NCBI
21	Coradini D, Pellizzaro C, Abolafio G, Bosco M, Scarlata I, Cantoni S, Stucchi L, Zorzet S, Turrin C, Sava G, et al: Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: A preclinical study. Invest New Drugs. 22:207–217. 2004. View Article : Google Scholar : PubMed/NCBI
22	Pan J, Sun SK, Wang Y, Fu YY, Zhang X, Zhang Y and Yu C: Facile preparation of hyaluronic acid and transferrin co-modified Fe₃O₄ nanoparticles with inherent biocompatibility for dual-targeting magnetic resonance imaging of tumors in vivo. Dalton Trans. 44:19836–19843. 2015. View Article : Google Scholar : PubMed/NCBI
23	Kondo H, Miyoshi K, Sakiyama S, Tangoku A and Noma T: Differential regulation of gene expression of alveolar epithelial cell markers in human lung adenocarcinoma-derived A549 clones. Stem Cells Int. 2015:1658672015. View Article : Google Scholar : PubMed/NCBI
24	Wang W, Zhou F, Ge L, Liu X and Kong F: Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomed. 7:2513–2522. 2012.
25	Jing L, Shao S, Wang Y, Yang Y, Yue X and Dai Z: Hyaluronic acid modified hollow Prussian blue nanoparticles loading 10-hydroxycamptothecin for targeting thermochemotherapy of cancer. Theranostics. 6:40–53. 2016. View Article : Google Scholar : PubMed/NCBI
26	Zhang XG, Miao J, Dai YQ, Du YZ, Yuan H and Hu FQ: Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm. 361:239–244. 2008. View Article : Google Scholar : PubMed/NCBI
27	Du YZ, Cai LL, Li J, Zhao MD, Chen FY, Yuan H and Hu FQ: Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles. Int J Nanomed. 6:1559–1568. 2011. View Article : Google Scholar
28	Yu W, Liu C, Liu Y, Zhang N and Xu W: Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res. 27:1584–1596. 2010. View Article : Google Scholar : PubMed/NCBI
29	Wang RH, Cao HM, Tian ZJ, Jin B, Wang Q, Ma H and Wu J: Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer. Oncol Rep. 33:783–791. 2015.PubMed/NCBI
30	Yu W, Liu C, Ye J, Zou W, Zhang N and Xu W: Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology. 20:2151022009. View Article : Google Scholar : PubMed/NCBI
31	Pepić I, Lovrić J, Hafner A and Filipović-Grčić J: Powder form and stability of Pluronic mixed micelle dispersions for drug delivery applications. Drug Dev Ind Pharm. 40:944–951. 2014. View Article : Google Scholar : PubMed/NCBI
32	Yu X, Yang G, Shi Y, Su C, Liu M, Feng B and Zhao L: Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance. Int J Nanomed. 10:7045–7056. 2015.
33	Zou W, Liu C, Chen Z and Zhang N: Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer. Int J Pharm. 370:187–195. 2009. View Article : Google Scholar : PubMed/NCBI
34	Vighi E, Montanari M, Hanuskova M, Iannuccelli V, Coppi G and Leo E: Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector. Int J Pharm. 440:161–169. 2013. View Article : Google Scholar : PubMed/NCBI
35	Hazzah HA, Farid RM, Nasra MM, El-Massik MA and Abdallah OY: Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: Development and characterization. Int J Pharm. 492:248–257. 2015. View Article : Google Scholar : PubMed/NCBI
36	Wang L, Dong J, Ouyang W, Wang X and Tang J: Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles. Oncol Rep. 27:719–726. 2012.PubMed/NCBI
37	Kumar MN Ravi, Bakowsky U and Lehr CM: Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials. 25:1771–1777. 2004. View Article : Google Scholar : PubMed/NCBI
38	Immordino ML, Brusa P, Rocco F, Arpicco S, Ceruti M and Cattel L: Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. J Control Release. 100:331–346. 2004. View Article : Google Scholar : PubMed/NCBI
39	Song RF, Li XJ, Cheng XL, Fu AR, Wang YH, Feng YJ and Xiong Y: Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors. Oncol Rep. 32:1481–1488. 2014.PubMed/NCBI
40	Torchilin VP: Multifunctional nanocarriers. Adv Drug Deliv Rev. 58:1532–1555. 2006. View Article : Google Scholar : PubMed/NCBI
41	Kamiya H, Tsuchiya H, Yamazaki J and Harashima H: Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv Drug Deliv Rev. 52:153–164. 2001. View Article : Google Scholar : PubMed/NCBI
42	Jiang HL, Hong SH, Kim YK, Islam MA, Kim HJ, Choi YJ, Nah JW, Lee KH, Han KW, Chae C, et al: Aerosol delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy. Int J Pharm. 420:256–265. 2011. View Article : Google Scholar : PubMed/NCBI